University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Nutrition and Health Sciences -- Faculty
Publications

Nutrition and Health Sciences, Department of

2017

Role of Oxygen Free Radicals, Nitric Oxide and
Mitochondria in Mediating Cardiac Alterations
During Liver Cirrhosis Induced by Thioacetamide
G. Jayakumar Amirtharaj
Christian Medical College, Vellore, India

Sathish Kumar Natarajan
University of Nebraska - Lincoln, snatarajan2@unl.edu

Anna Pulimood
Christian Medical College, Vellore, India

K. A. Balasubramanian
Christian Medical College, Vellore, India

Aparna Venkatraman
Christian Medical College, Vellore, India
See next page for additional authors

Follow this and additional works at: http://digitalcommons.unl.edu/nutritionfacpub
Part of the Human and Clinical Nutrition Commons, Molecular, Genetic, and Biochemical
Nutrition Commons, and the Other Nutrition Commons
Amirtharaj, G. Jayakumar; Natarajan, Sathish Kumar; Pulimood, Anna; Balasubramanian, K. A.; Venkatraman, Aparna; and
Ramachandran, Anup, "Role of Oxygen Free Radicals, Nitric Oxide and Mitochondria in Mediating Cardiac Alterations During Liver
Cirrhosis Induced by Thioacetamide" (2017). Nutrition and Health Sciences -- Faculty Publications. 106.
http://digitalcommons.unl.edu/nutritionfacpub/106

This Article is brought to you for free and open access by the Nutrition and Health Sciences, Department of at DigitalCommons@University of
Nebraska - Lincoln. It has been accepted for inclusion in Nutrition and Health Sciences -- Faculty Publications by an authorized administrator of
DigitalCommons@University of Nebraska - Lincoln.

Authors

G. Jayakumar Amirtharaj, Sathish Kumar Natarajan, Anna Pulimood, K. A. Balasubramanian, Aparna
Venkatraman, and Anup Ramachandran

This article is available at DigitalCommons@University of Nebraska - Lincoln: http://digitalcommons.unl.edu/nutritionfacpub/106

AMIRTHARAJ ET AL. IN CARDIOVASCULAR TOXICOLOGY 17 (2017)

1

Published in Cardiovascular Toxicology 17:2 (April 2017), pp. 175-184.
doi 10.1007/s12012-016-9371-1
Copyright © 2016 Springer Science+Business Media New York. Used by permission.
Published online April 30, 2016.
PMID: 27131982
________________________________________________________________________________________________

Role of Oxygen Free Radicals, Nitric Oxide
and Mitochondria in Mediating Cardiac
Alterations During Liver Cirrhosis
Induced by Thioacetamide
G. Jayakumar Amirtharaj,1 Sathish Kumar Natarajan,1,3
Anna Pulimood,1 K. A. Balasubramanian,1
Aparna Venkatraman,2 and Anup Ramachandran1
1 The Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences,
Christian Medical College, Ida Scudder Road, Vellore 632004, India
2 Center for Stem Cell Research, Christian Medical College, Ida Scudder Road,
Vellore 632004, India
3 IANR, Nutrition & Health Sciences, University of Nebraska–Lincoln, Lincoln, NE
68583-0806, USA
Corresponding author — Anup Ramachandran, wellcome@cmcvellore.ac.in

Abstract
Thioacetamide (TAA) administration is widely used for induction of liver cirrhosis
in rats, where reactive oxygen radicals (ROS) and nitric oxide (NO) participate in
development of liver damage. Cardiac dysfunction is an important complication of
liver cirrhosis, but the role of ROS or NO in cardiac abnormalities during liver
cirrhosis is not well understood. This was investigated in animals after TAA-induced
liver cirrhosis and temporal changes in oxidative stress, NO and mitochondrial
function in the heart evaluated. TAA induced elevation in cardiac levels of nitrate
before development of frank liver cirrhosis, without gross histological alterations.
This was accompanied by an early induction of P38 MAP kinase, which is influenced
by ROS and plays an important signaling role for induction of iNOS. Increased
nitrotyrosine, protein oxidation and lipid peroxidation in the heart and cardiac
mitochondria, suggestive of oxidative stress, also preceded frank liver cirrhosis.
However, compromised cardiac mitochondrial function with a decrease in
respiratory control ratio and increased mitochondrial swelling was seen later, when
cirrhosis was evident. In conclusion, TAA induces elevations in ROS and NO in the
heart in parallel to early liver damage. This leads to later development of functional
deficits in cardiac mitochondria after development of liver cirrhosis.
Keywords: Heart, Oxidative stress, Liver, p38 MAP kinase, Thioacetamide
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Introduction
Liver cirrhosis is a chronic disease characterized by hepatic fibrosis induced
by progressive hepatocyte injury and stellate cell activation. Thioacetamide
(TAA) administration is a widely used model for development of liver
cirrhosis in animals which reproduces the human disease induced by a
number of different etiologies. TAA hepatotoxicity requires its
biotransformation to TAA-S-oxide and subsequently to the highly reactive
metabolite TAA-S-dioxide by hepatic microsomal CYP2E1 [1]. Early studies
from the late 1940s suggest that the liver is the main organ affected by
administration of TAA [2–4], and chronic feeding of TAA to rats affected
only the liver with no changes to other organs like the lung, heart, spleen
[3]. However, only gross abnormalities were generally examined in those
studies, and the role of reactive oxygen species (ROS) and nitric oxide (NO)
in cardiac changes after TAA is not well understood. This is relevant since
cardiac alterations during later stages of cirrhosis in humans could be the
underlying cause for development of life-threatening complications such
as the hepatorenal syndrome, ascites, spontaneous bacterial peritonitis
(SBP) and the hepatopulmonary syndrome [5]. Cirrhotic children have
cardiac dysfunction mainly in the form of diastolic dysfunction [6], and
functional deficits in the heart in patients with liver disease may only
become evident during pharmacological or physiological stress, when
compensatory mechanisms of the heart become insufficient to maintain
adequate cardiac output [7]. Though mechanisms involved in cardiac
dysfunction in hepatic disease are not fully understood, it has been
suggested that early detection of this condition is important [8].
Nitric oxide (NO) is an important vasodilator in the splanchnic and
systemic circulation at low concentrations, but at higher levels, the
molecule can have a number of damaging effects. Patients with cirrhosis
exhibit elevated NO levels in the systemic and splanchnic circulation [9],
and inhibition of iNOS in cirrhotic rats abrogates the effects of NO and
improves cardiac contractility, suggesting a role for NO in cardiac
pathophysiology [10]. In addition, NO can react with free radicals such as
superoxide resulting in the generation of peroxynitrite, which can enhance
cellular toxicity [11].
Oxygen free radicals have been implicated in the pathogenesis of toxic
liver injury [12], and oxidative stress during liver cirrhosis is responsible for
intestinal and renal damage [13–15]. Oxidative stress has been suggested
to be involved in cardiac dysfunction in the cirrhotic heart [16], and an
increase in lipid peroxidation markers has been demonstrated in the
kidney, brain and heart of rats with cholestatic liver disease suggesting
oxidative damage to different organs [17]. Mitochondria are an important
cellular source as well as target of oxygen free radicals, and intestinal and
renal mitochondria have been shown to be significantly affected in liver
cirrhosis [13, 15]. However, the temporal relationship between TAAinduced development of liver cirrhosis and changes in ROS and NO in the
heart as well as its effect on cardiac mitochondrial function are not well
understood and were investigated in this study. We hypothesized that
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generation of oxygen free radicals and NO during TAA-induced cirrhosis
results in oxidative and nitrosative damage in the heart, which affects
mitochondrial function. This hypothesis was tested by examining
alterations in the rat heart and liver over time after administration of TAA.

Methods
Animals and Induction of Liver Cirrhosis
The study was approved by the Institutional Animal Ethics Committee
(IAEC) at the Christian Medical College, Vellore, and experimentation,
transportation and care of the animals were performed in compliance with
relevant laws and institutional guidelines. Adult Wistar rats of both sexes
(125–200 g) were administered intraperitoneal injections of TAA (200
mg/kg, ip) in saline twice a week for 2, 3, 4, 5 and 6 months. Some
experiments had a group treated for 1 month. Control rats received vehicle
alone [18]. After each treatment period, TAA was stopped and the animals
were killed after 1 week.
Light and Electron Microscopy (EM)
For light microscopy, tissues were fixed in 10 % buffered formalin and
processed. Four-micron sections were cut and stained with hematoxylin
and eosin. For EM, heart tissue was fixed in 2.5 % glutaraldehyde, postfixed in osmium tetroxide and embedded in araldite (epoxy resin). Onemicron-thick sections were cut and stained with toluidine blue. Ultrathin
sections were cut on an LKB UM4 ultramicrotome, sections mounted on
copper grids, and stained with uranyl acetate and lead citrate. The grids
were examined under a Philips TECHNAI T12 SPIRIT transmission electron
microscope.
Measurement of Nitrate and Oxidative Stress Parameters
Nitrate in the samples was measured by the Griess reaction as described
[19]. Malondialdehyde (MDA), conjugated dienes and protein carbonyl
content was measured as described [20–22]. Protein was estimated by
Lowry’s method [23].
Western Blot for p38 MAPK
Twenty-microgram samples of heart protein were separated by SDS-PAGE,
blotted onto PVDF membrane and probed with anti-p38 MAPK (rabbit
polyclonal, Cell Signaling Technology) and anti-phospho-p38 MAPK
(mouse monoclonal, Cell Signaling Technology). Following treatment with
HRP-linked secondary antibodies, membranes were developed by
enhanced chemiluminescence and bands quantitated with Image J
software.
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Staining for Nitrotyrosine
Paraffin sections were blocked with universal blocking buffer (Biogenex)
after antigen retrieval, followed by incubation with an anti-nitrotyrosine
antibody (Clone-39B6) (1:100 dilution, Santa Cruz) overnight at 4 °C. Slides
were then incubated with secondary antibody, and immunostained
sections visualized using a confocal microscope (Olympus FluoView™
FV1000).
Isolation of Heart Mitochondria and Mitochondrial Functional
Assays
Heart mitochondria were isolated by differential centrifugation as
described [13] after homogenization in buffer containing 225 mM
Mannitol, 75 mM Sucrose, 10 mM Tris, 1 mM EDTA pH 7.4. Mitochondrial
oxygen uptake and swelling were then measured [13, 24]. MTT assay was
carried out as described [25].
Statistical Analysis
Data are expressed as mean ± SEM. Statistical analysis was performed
using Student’s t test. A probability value of <0.05 was taken to indicate
statistical significance.

Results
To confirm development of liver cirrhosis in rats after TAA treatment, liver
sections from rats treated with either saline or TAA for 3 or 6 months were
evaluated by light microscopy. Control livers showed normal liver
architecture (Fig. 1a), with no significant changes in hepatocytes and portal
tracts. These features were not altered after 2 months of TAA treatment
(data not shown). However, by 3 months, rats treated with TAA showed
characteristics of cirrhosis, with the formation of nodules separated by
septae, infiltration by moderate numbers of inflammatory cells and
fibroblasts with proliferating bile ductules (Fig. 1b). By 6 months of TAA
treatment, histological changes in the liver were similar to those seen at 3
months, but with more uniformly thick septae (Fig. 1c).
Histological changes in the heart were then examined, and the heart
from control rats showed normal cardiac muscle fibers with elongated
nuclei exhibiting fine chromatin and eosinophilic cytoplasm. There was
no evidence of vacuolization, fibrosis or inflammation (Fig. 1d). The heart
from cirrhotic rats at both 3 and 6 months of TAA treatment did not show
any gross cellular abnormality compared to hearts from control rats,
though congestion of capillaries between cardiac muscle fibers was visible
(Fig. 1e, f).
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Nitric oxide has been shown to be involved in cardiac damage after liver
cirrhosis [11], and further experiments examined the temporal profile of
nitrate, an NO metabolite, in the heart during TAA-induced cirrhosis. As
seen in Fig. 2a, nitrate levels increased significantly by 2 months. These
levels do not change considerably by 3 months, but begin to progressively
increase further from 4 months, increasing up to 5 months after TAA.
Probable signaling events controlling this elevation in NO in the heart
during liver cirrhosis were then examined. Cardiac levels of iNOS mRNA
and protein have been shown to be elevated in cirrhotic rats [10], and p38
MAPK has been suggested to be essential for the expression of iNOS in
cardiac tissue [26]. Western blot analysis showed an increase in levels of
p38 protein in the heart within a month of treatment with TAA, which did
not alter significantly subsequently. Activation of p38, as measured by
phosphorylation at Thr180/Tyr182, was significantly elevated by 1 month
and increased further at 3 and 5 months after TAA treatment (Fig. 2b).
Since p38 MAPK can be induced by reactive oxygen species (ROS) [27], the
presence of ROS was next evaluated in the cirrhotic heart.
Markers of lipid peroxidation such as malondialdehyde and conjugated
diene began rising in heart tissue by 2 months of TAA treatment (before
establishment of gross cirrhotic changes by histology) and peaked by 3
months when cirrhotic changes in the liver were evident by histology (Fig.
3a, b). Oxidative changes to cardiac proteins were also evident, as seen by
an elevation in protein carbonyl content, which was also initiated at 2
months, but peaked at 4 months, in contrast to lipid peroxidation data (Fig.
3c). These elevations in malondialdehyde, conjugated diene and protein
carbonyl content suggest significant oxidant stress in the heart.
Concurrent elevations in free radicals such as superoxide and NO can
result in the formation of peroxynitrite, which modifies proteins to
generate nitrotyrosine. Since both NO and oxidant stress were elevated in
the heart at early time points, the presence of nitrotyrosine was evaluated
in the heart as an index of peroxynitrite formation. As seen in Fig. 4, a
significant increase in staining for nitrotyrosine was evident in the
cardiomyocytes of the heart by 1 month, concurrent with elevation in NO
as well as oxidant stress markers.
Since mitochondria are an important target as well as source of free
radicals within the cell, we next evaluated cardiac mitochondrial function
during development of liver cirrhosis. Cardiac mitochondria showed a
decreased respiratory control ratio (Fig. 5a) which was evident by 3 months
of TAA treatment and continued until 6 months. This was accompanied by
an increase in mitochondrial swelling as seen by the decrease in
absorbance at 540 nm (Fig. 5b) indicative of activation of the mitochondrial
permeability transition (MPT). This was initiated by 3 months and
progressively increased until 6 months of TAA treatment. These changes
were confirmed by electron microscopy, which demonstrated patchy
cardiac mitochondrial dilation with loss of cristae in animals after 3 (Fig.
6b, e) or 6 months (Fig. 6c, f) of TAA treatment, while normal control rat
hearts showed cardiomyocytes with normal mitochondria and myofibrils
(Fig. 6a, d). Thus, measurements of cardiac mitochondrial functional
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parameters and electron microscopy indicate that significant functional
impairment of cardiac mitochondria occur in rats after development of
cirrhosis. While the oxidative stress in heart tissue was found to start
increasing at 2 months and peak at 3–4 months followed by a decrease,
mitochondrial functional alterations were initiated later and were
progressive (Fig. 5c).
The role of oxidative stress in mediating these mitochondrial alterations
was then investigated by measuring the rate of radical production within
mitochondria using MTT reduction, which has been shown to be elevated
in kidney and intestinal mitochondria during cirrhosis [13, 15]. As seen in
Fig. 7a, an increased rate of MTT reduction was evident in cirrhotic rats
beginning by 3 months, which stayed elevated subsequently. The
consequence of this elevated mitochondrial radical production was next
examined, and an increase in malondialdehyde levels was evident in heart
mitochondria by 2 months of TAA treatment, which peaked by 3 months,
similar to changes seen in the heart (Fig. 7b). Conjugated diene levels also
increased by 2 months of TAA treatment and reached a maximum by 3
months and stayed elevated till 6 months of TAA treatment (Fig. 7c).
Protein carbonyl content in mitochondria, however, started to increase
significantly only by 3 months and then peaked at 4 months after TAA
treatment (Fig. 7d). Thus, lipid peroxidation in the mitochondria seems to
precede changes in protein oxidation as well as functional defects in
cardiac mitochondria, implicating it in the subsequent derangement of
cardiac mitochondrial function during TAA-induced liver cirrhosis.

Discussion
Thioacetamide Induces Early Elevations in Cardiac Nitric Oxide
Levels Prior to Liver Cirrhosis
Nitric oxide (NO) has been implicated in renal and cardiac complications
during liver cirrhosis [11]. Early studies examining cardiac function in biliary
cirrhosis in the rat suggested a role for NO in pathophysiology of cirrhotic
cardiomyopathy [28]. It was subsequently shown that cardiac levels of
TNF-alpha and iNOS mRNA and protein, as well as serum nitrite/nitrate
levels, were significantly higher in cirrhotic rats than sham controls [10].
However, most of the earlier studies examined cardiac alterations after
development of liver cirrhosis, and our data now show that elevations of
NO in the heart occur prior to development of frank cirrhosis in the liver
after administration of TAA. While this is unlikely to be a direct effect of
TAA since the compound requires hepatic metabolism to produce toxicity
[29], the role of circulating TAA metabolites in the process cannot be ruled
out. However, it has been shown that TAA administration does not directly
produce alterations in the heart [30], and cardiac modifications occurring
in ascitic rats with biliary cirrhosis are related to NO [28]. The fact that bile
duct ligation per se, without cirrhosis, resulted in elevation of cardiac
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mRNA, and protein for iNOS [16] lends further credence to this possibility
that early liver damage itself can upregulate NO production in the heart
irrespective of the trigger.

Thioacetamide-Induced Liver Injury Results in Early Activation of the
p38 MAPK
Cholestasis in the liver results in elevated plasma TNF-α in mice,
accompanied by increased cardiac mRNA and protein expression of p38
MAPK and iNOS [16]. Activation of p38 MAPK can contribute to loss of
cardiac contractility [31] and also regulate NO production [32]. Our data
now show that activation of molecular mediators such as p38 MAPK in the
heart occurs early in the disease process, in parallel to development of liver
injury. The initial elevation could be due to increased protein synthesis, but
subsequently there is a robust phosphorylation of the protein resulting in
its sustained activation. Activation of p38 MAPK in cholestatic mice was
accompanied by changes in glutathione and antioxidant enzymes
suggestive of oxidant stress [16], and the damaging effects of NO can be
amplified several fold by its reaction with free radical intermediates such
as superoxide [33], implicating oxidative stress in cardiac damage during
TAA-induced cirrhosis.
Oxidative and Nitrosative Stress in the Heart Precedes Development
of Frank Cirrhosis in the Liver
Liver cirrhosis can induce functional alterations in the intestine [13, 14] and
kidney [15] due to oxidant stress, which has also been demonstrated in
mice cardiac cells after bile duct ligation [34]. Our data now show that
elevations in protein carbonyl and malondialdehyde are evident in the
heart before development of frank cirrhosis in the liver after TAA
administration. This indicates that oxidant stress in the heart is not merely
a consequence of liver cirrhosis, but is initiated earlier, before frank
cirrhosis is evident in the liver. Simultaneous elevations in NO and
superoxide can result in formation of peroxynitrite, which compromises
protein function by formation of nitrotyrosine [35]. It has been
demonstrated that nitration of cardiac proteins is associated with
abnormal cardiac chronotropic responses in rats with biliary cirrhosis [36].
Our data now show elevated nitrotyrosine levels in the heart of TAAtreated animals within a month after treatment indicating that formation
of peroxynitrite and nitrosative stress in the heart is also an early event in
conjunction with oxidant stress.
Liver Cirrhosis Induces Significant Functional Alterations in Cardiac
Mitochondria
Mitochondria are critical organelles for cellular function, especially in
energy intensive organs such as the heart, and mitochondrial oxidative
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stress plays a role in dysfunction of the organelle in heart failure [37].
Impaired mitochondrial function and dynamics have been shown to induce
myocardial contractile dysfunction in patients with type 2 diabetes [38],
and our data now show that this organelle is a sensitive target in the heart,
albeit at later stages after development of liver cirrhosis. The uncoupling
of mitochondrial respiration and oxidative phosphorylation, producing the
decrease in respiratory control ratio, was evident by 3 months, at which
time cirrhosis is evident histologically in the liver. A similar decrease in
respiratory control ratio has been observed in failed human myocardial
tissue [39], and diabetic hearts were also shown to have lower ATP levels
and compromised mitochondrial respiration [40]. An important feature of
cellular injury is activation of the mitochondrial permeability transition
(MPT) pore, which can be induced by oxidative stress [41]. It is interesting
that while uncoupling of respiration was evident by 3 months and
subsequently did not change, the induction of the mitochondrial
permeability transition was significant only at 4 months and then
continued to worsen each month until the sixth month. This indicates that
the MPT induction in cardiac mitochondria was a later event subsequent
to mitochondrial uncoupling.
Lipid Peroxidation Could Initiate Cardiac Mitochondrial Dysfunction
in TAA-Induced Cirrhosis
The mitochondrion is a source as well as a target for reactive oxygen
species, and production of ROS within mitochondria has been
demonstrated in heart failure [42]. The early elevation in lipid peroxidation
within cardiac mitochondria by 2 months of TAA, prior to development of
frank liver cirrhosis, may result in downstream effects since lipid
peroxidation has been shown to induce uncoupling of mitochondrial
respiration [43], probably by activation of uncoupling proteins in
mitochondria [44]. Lipid peroxidation has also been shown in mouse heart
mitochondria after myocardial infarction when mitochondrial dysfunction
was evident [45]. Cardiac mitochondrial uncoupling then results in
elevated free radical production, as seen by MTT reduction which was
significantly elevated by 3 months, and sustained subsequently. This seems
to be similar to that seen in both the intestine and the kidney in cirrhotic
rats [13, 15]. This then suggests that early induction of lipid peroxidation
in the heart could be responsible for the subsequent mitochondrial
dysfunction, which exacerbates as the liver injury intensifies.
In conclusion, we demonstrate early elevations in NO, activation of p38
MAP kinase, induction of lipid peroxidation and nitrosative stress in cardiac
tissue prior to development of frank liver cirrhosis after TAA
administration. Though the mitochondria are likely sources for these free
radicals, organelle function in the heart is only compromised at later time
points after development of liver cirrhosis. Thus, while functional cardiac
alterations occur after development of liver cirrhosis and the resultant
circulatory abnormalities, molecular alterations within the heart could be
occurring earlier. While the cardiac changes are probably not responsible
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for the changes in the liver, the data imply that early changes in the liver
before development of frank cirrhosis probably induce oxidative and
nitrosative stress in the heart, which primes the organ for functional
deficits at later time points after frank cirrhosis has developed. Hence,
signaling events and subcellular alterations are initiated very early in
cardiac tissue during development of liver cirrhosis after TAA
administration, and the cumulative effect of these alterations could play
an important role in cardiac complications later in liver disease.

Fig. 1. Histology of liver and heart from rats treated with TAA: light microscopy of liver (a–c)
and heart (d–f) from control and rats treated with TAA for either 3 or 6 months. a, d Control;
b, e 3 months; c, f 6 months. Original magnification ×400.
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Fig. 2. Nitric oxide and p38 MAPK in the heart during development of liver cirrhosis: a) nitrate
levels in heart from controls and TAA-treated rats. The data are expressed as mean ± SEM, n
= 4–6. * P < 0.05 when compared to controls. # P < 0.05 when compared to 5 months. b)
Phospho-p38 MAP kinase protein expression in heart from controls and TAA-treated rats.
The data are expressed as mean ± SEM, n = 4. * P < 0.05 when compared to controls.
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Fig. 3. Oxidative stress parameters in heart from controls and TAA-treated rats:
malondialdehyde (a), conjugated diene (b) and protein carbonyls (c). The data are expressed
as mean ± SEM, n = 3–5. * P < 0.05 when compared to controls.
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Fig. 4. Nitrotyrosine staining in the heart after administration of TAA: immunofluorescence
staining for nitrotyrosine in sections of cardiac tissue from controls and rats treated with TAA
for 1 month. NT nitrotyrosine staining, DIC differential interference contrast image, DAPI
nuclear staining).
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Fig. 5. Cardiac mitochondrial function after administration of TAA: cardiac mitochondrial
functional parameters such as respiratory control ratio (a) and mitochondrial swelling (b)
from controls and TAA-treated rats. The data are expressed as mean ± SEM, n = 3–5. * P <
0.05 when compared to controls. (c) Overlay of temporal changes in oxidant stress in the
heart and cardiac mitochondrial function in animals treated with TAA when compared to
controls.
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Fig. 6. Electron micrographs of hearts from rats treated with TAA: control animals showing
normal mitochondria (a ×6000, b ×43,000) (arrows). Cardiac tissue after 3 (c ×6000, d
×43,000) and 6 (e ×6000, f ×43,000) months showing mitochondrial dilation with loss of
cristae (asterisks).
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Fig. 7. Superoxide production and oxidative stress parameters in cardiac mitochondria from
cirrhotic rats: MTT reduction (a) and oxidative stress parameters such as malondialdehyde
(b), conjugated diene (c) and protein carbonyls (d) in cardiac mitochondria from controls
and TAA-treated rats. The data are expressed as mean ± SEM, n = 3–5. * P < 0.05 when
compared to controls.
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